Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Twice a Day Clopidogrel vs Ticagrelor in Reducing Major Cardiac Events in Patients With Acute STEMI Undergoing Primary Percutaneous Intervention- TADCLOT- a Double Blind Randomized Controlled Trial

NCT06318481 is registered in ClinicalTrials.gov with National Institute of Cardiovascular Diseases, Pakistan as lead sponsor.

NCT NCT06318481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06318481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Twice a Day Clopidogrel vs Ticagrelor in Reducing Major Cardiac Events in Patients With Acute STEMI Undergoing Primary Percutaneous Intervention- TADCLOT- a Double Blind Randomized Controlled Trial
Lead sponsor
National Institute of Cardiovascular Diseases, Pakistan
Phase
Phase 3
Overall status
Completed
Start date
February 19, 2024
Completion date
February 20, 2025
Enrollment
2,200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction, acute, stent thrombosis